Editorial: Taking FIT to the people: Out of the office and into the mail

American Journal of Gastroenterology

Volumn 107, Issue 1, 2012, Pages 108-110

  Levin, Theodore R ^a  

^a KAISER PERMANENTE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

CANCER SCREENING; COLORECTAL CANCER; DEVICES; DIAGNOSTIC VALUE; FECAL IMMUNOCHEMICAL TEST; FECES ANALYSIS; HEALTH CARE ACCESS; HUMAN; IMMUNOCHEMISTRY; POSTAL MAIL; PRIORITY JOURNAL; REVIEW; SCREENING TEST;

COLORECTAL NEOPLASMS; FECES; FEMALE; HEMOGLOBINS; HUMANS; MALE; SPECIMEN HANDLING;

EID: 84855426409     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2011.401     Document Type: Review

References (18)

1. Richardson LC, Tai E, Rim SH, et al. Vital signs: colorectal cancer screening, incidence, and mortality-United States, 2002-2010. MMWR Morb Mortal Wkly Rep 2011; 60: 884-9.
2. Richardson LC, Rim SH, Plescia M. Vital signs: colorectal cancer screening among adults aged 50-75 years-United States, 2008. MMWR Morb Mortal Wkly Rep 2010; 59: 808-12.
3. Ioannou GN, Chapko MK, Dominitz JA. Predictors of colorectal cancer screening participation in the United States. Am J Gastroenterol 2003; 98: 2082-91. (Pubitemid 37185810)
4. Benuzillo J, Jacobs E, Hoff man R et al. Rural-urban diff erences in colorectal cancer screening capacity in Arizona. J Community Health 2009; 34: 523-8.
5. Naishadham D, Lansdorp-Vogelaar I, Siegel R et al. State disparities in colorectal cancer mortality patterns in the United States. Cancer Epidemiol Biomarkers Prev 2011; 20: 1296-302.
6. Park DI, Ryu S, Kim YH et al. Comparison of guaiac-based and quanti tative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening. Am J Gastroenterol 2010; 105: 2017-25.
7. Allison JE, Tekawa IS, Ransom LJ et al. A comparison of fecal occult-blood tests for colorectal-cancer screening. N Engl J Med 1996; 334: 155-9. (Pubitemid 26017953)
8. Allison JE, Sakoda LC, Levin TR et al. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. J Natl Cancer Inst 2007; 99: 1462-70.
9. Inadomi JM, Vijan S, Janz NK et al. Method of recommendation for colorectal cancer screening strategies impacts adherence. Gastroenterology 2010; 138: S-23.
10. ClinicalTrials.gov listing, Colonoscopy versus Fecal Immunochemical Testing in Reducing Mortality from Colorectal Cancer (CONFIRM). http://clinicaltrials.gov/ct2/show/NCT01239082.
11. Zauber AG, Lansdorp-Vogelaar I, Knudsen AB et al. Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force. Ann Intern Med 2008; 149: 659-69.
12. Hoff G, Dominitz JA. Contrasting US and European approaches to colorectal cancer screening: which is best? Gut 2010; 59: 407-14.
13. Levin TR, Jamieson L, Burley DA et al. Organized colorectal cancer screening in integrated health care systems. Epidemiol Rev 2011; 33: 101-10.
14. Benson VS, Patnick J, Davies AK et al. Colorectal cancer screening: a comparison of 35 initiatives in 17 countries. Int J Cancer 2008; 122: 1357-67. (Pubitemid 351287237)
15. Levin TR. Optimizing colorectal cancer screening by getting FIT right. Gastroenterology 2011; 141: 1551-5.
16. Van Roon AHC, Hol L, Vuuren AJV et al. Are fecal immunochemical test characteristics infl uenced by sample return time? A population-based colorectal cancer screening trial: Effect of sample return time on FIT characteristics. Am J Gastroenterol 2012;107:99-107 (this issue).
17. Grazzini G, Ventura L, Zappa M et al. Infl uence of seasonal variations in ambient temperatures on performance of immunochemical faecal occult blood test for colorectal cancer screening: observational study from the Florence district. Gut 2010; 59: 1511-5.
18. Rennert G. Colorectal cancer screening: will global warming aff ect the accuracy of FIT testing? Gut 2010; 59: 1451-2.